burn
Conditions
Interventions
Autologous-allogeneic MEEK graft group:Autologous allogeneic MEEK skin alternating graft
autologous MEEKgraft group :Autologous MEEK skin graft
Sponsors
the 990th Hospital of Joint Logistics Support Force
Eligibility
Sex/Gender
All
Age
1 Years to 60 Years
Inclusion criteria
Inclusion criteria: Subjects enrollment criteria: (Prior to the experiment, subjects must meet all the requirements under the item to be enrolled) (1) Age 1-60 years, regardless of gender; 2) Have signed an informed consent form for MEEK implant surgery; 3) Patients agree to participate in this experiment and sign an informed consent form; 4) those whose infectious diseases such as hepatitis A, hepatitis B, AIDS, and tuberculosis are not in the active stage; (5) Subjects with burns on the anterior and posterior trunk or limb areas. Donor selection criteria: (before the experiment, the donor must meet all the requirements below to be enrolled) 1) Age 18-60 years old, regardless of gender, and be a close relative of the patient; 2) Have signed an informed consent form for MEEK implant surgery; 3) the patient agrees to participate in this experiment and signs an informed consent form (4) Hepatitis A, hepatitis B, AIDS, tuberculosis and other infectious diseases are not in the active stage.
Exclusion criteria
Exclusion criteria: Subject exclusion criteria: (subjects meeting any one of the requirements under the item may not be enrolled) 1) Severe infection of burn wounds; 2) Patients with diabetes mellitus; 3) Those with serious organic lesions of the heart, brain, liver, kidney, lungs and other organs; 4) those with severe mental illnesses with potential risk of resistance 5) those with systemic debilitating diseases: e.g. malignant tumors, etc; 6) women during pregnancy; 7) Those with a history of severe allergies or poor compliance with the experiment 8) Patients with diseases that are considered by the investigator to be inappropriate for participation in this clinical trial. Donor exclusion criteria: (Subjects who meet any of the requirements under the item before the experiment may not be enrolled) 1) Patients with diabetes mellitus; 2) Patients with severe organic lesions of the heart, brain, liver, kidney, lungs and other organs; 3) Those with severe mental illnesses with potential risk of resistance; 4) those with systemic debilitating diseases: e.g. malignant tumors, etc; 5) women during pregnancy; 6) Those with a history of severe allergies or poor compliance with the experiment 7) Patients with diseases that are considered by the investigator to be inappropriate for participation in this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| wound healing time; | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of implant procedures;Keloidal hyperplasia;wound infection;Healing time of the donor area;Number of skin donations;Length of stay;Inpatient costs;complication; | — |
Countries
China
Contacts
Public Contactyantiantian
the 990th Hospital of Joint Logistics Support Force
Outcome results
None listed